<?xml version="1.0"?>
<rss version="2.0" xmlns:prism="http://purl.org/rss/1.0/modules/prism/">
  <channel>
    <title>JAMA Ophthalmology: Prostate Cancer Topic Collection</title>
    <link>http://archopht.jamanetwork.com/</link>
    <description>
    </description>
    <language>en-us</language>
    <pubDate>Mon, 24 Dec 2012 00:00:00 GMT</pubDate>
    <lastBuildDate>Tue, 01 Jan 2013 00:51:13 GMT</lastBuildDate>
    <generator>Silverchair</generator>
    <managingEditor>editor@archopht.jamanetwork.com</managingEditor>
    <webMaster>webmaster@archopht.jamanetwork.com</webMaster>
    <item>
      <title>Leuprolide Monotherapy for Choroidal Metastasis From Prostate Adenocarcinoma</title>
      <link>http://archopht.jamanetwork.com/article.aspx?articleID=1357932</link>
      <pubDate>Sat, 01 Sep 2012 00:00:00 GMT</pubDate>
      <author>Ameri H, Araujo JC, Gombos DS. </author>
      <description>&lt;span class="paragraphSection"&gt;Prostate cancer is the most common malignant neoplasm in men in developed countries and the second most common worldwide. Androgen deprivation therapy is often used for recurrent or metastatic disease. Gonadotropin-releasing hormone agonists such as leuprolide acetate are the most frequently used medications for this purpose.&lt;/span&gt;</description>
      <prism:volume xmlns:prism="prism">130</prism:volume>
      <prism:number xmlns:prism="prism">9</prism:number>
      <prism:startingPage xmlns:prism="prism">1225</prism:startingPage>
      <prism:endingPage xmlns:prism="prism">1226</prism:endingPage>
      <prism:doi xmlns:prism="prism">10.1001/archophthalmol.2012.458</prism:doi>
      <guid>http://archopht.jamanetwork.com/article.aspx?articleID=1357932</guid>
    </item>
  </channel>
</rss>